Seventy nine percent of tumors with mutations and 53

Info iconThis preview shows page 1. Sign up to view the full content.

View Full Document Right Arrow Icon
This is the end of the preview. Sign up to access the rest of the document.

Unformatted text preview: mors with mutations and 53% of tumors with multiple copies of KIT demonstrated increased KIT protein levels (57). p16INK4A : Sporadic and familial melanomas have been associated with mutations, loss of heterozygosity, and deletions in the CDKN2A locus, which is important for the normal progression of the cell cycle. Somatic inactivation of CDKN2A (p16INK4A and p14ARF) is frequently detected in melanoma cell lines but less commonly in primary tumors (58). Biallelic CDKN2A deletions however, have been reported in about 45% of CMM metastases and associated with adverse prognosis, emphasizing the importance of this locus in disease progression (59). Expression of p16INK4A has been reported to correlate inversely with aggressive melanoma behavior; nevertheless, mutations at this locus also have been detected in normal melanocytes and in benign compound nevi lacking signs of clinical or histologic atypia (27). p53 and p14ARF: Mutations in TP53 (the p53 gene) are the most common contributors to the etiology of neoplastic disorders, but their role in the pathogenesis 16 of melanoma has not been established. TP53 mutations are in infrequent in primary human melanoma, thus, there is no apparent correlation between TP53 gene rearrangements or altered expression of the p53 protein and progression of melanocytic lesions. Nevertheless, some authors suggest that p53 could have a more complex role in the pathogenesis of melanoma by acting on downstream effector genes, such as HDM2, GADD45, and CIP1/WAF1 (27). ARF has been thought to function predominantly as a positive regulator of the p53 tumor suppressor through inhibition of HDM2. Loss of ARF could thus explain the lack of TP53 mutations in melanomas. However, experimental evidence has recently showed, that ARF functions as a tumor suppressor by inducing p53-independent senescence. Accordingly, ARF– and p53- deficient mice do not exhibit identical tumor phenotypes, and ARF interacts with a variety of other proteins, including E2F1, Myc, NF-κB, and can function independently of p53 in ribosome biosynthesis, DNA damage response, apoptosis, and autophagy (60). Chromosomal abnormalit...
View Full Document

This document was uploaded on 03/06/2014.

Ask a homework question - tutors are online